(Q37563966)

21 August 2017

1 reference

title

Reappraising the stereotypes of diabetes in the modern diabetogenic environment (English)

1 reference

21 August 2017

1 reference

John M Wentworth

1

1 reference

21 August 2017

Spiros Fourlanos

series ordinal

2

1 reference

21 August 2017

Leonard C Harrison

series ordinal

3

1 reference

21 August 2017

publication date

28 July 2009

1 reference

Nature Reviews Endocrinology

21 August 2017

published in

1 reference

21 August 2017

volume

5

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

483-489

1 reference

Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Diagnosis and classification of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Risk assessment, prediction and prevention of type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Latent autoimmune diabetes in adults (LADA) should be less latent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

31 March 2020

Declassifying diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

The rise of childhood type 1 diabetes in the 20th century.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Insulin resistance is a risk factor for progression to type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Models for predicting type 1 diabetes in siblings of affected children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Role of insulin resistance in predicting progression to type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Energy intake/physical activity interactions in the homeostasis of body weight regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Trans fatty acids, insulin resistance, and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Fructose, weight gain, and the insulin resistance syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

The effect of infections on susceptibility to autoimmune and allergic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Hay fever, hygiene, and household size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

NOD mouse colonies around the world--recent facts and figures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Type 1 diabetes: lessons for other autoimmune diseases?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Microbial ecology: human gut microbes associated with obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

An obesity-associated gut microbiome with increased capacity for energy harvest

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Vitamin D deficiency: a worldwide problem with health consequences.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Energy metabolism in women during short exposure to the thermoneutral zone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Obstructive sleep apnea and type 2 diabetes: interacting epidemics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

We are chronically sleep deprived.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Risk factors for childhood overweight: a prospective study from birth to 9.5 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

The association between short sleep duration and obesity in young adults: a 13-year prospective study

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

31 March 2020

12 December 2020

A prospective study of self-reported sleep duration and incident diabetes in women

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Impact of sleep debt on metabolic and endocrine function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Inflammation and metabolic disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

CCR2 modulates inflammatory and metabolic effects of high-fat feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Increased number of islet-associated macrophages in type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

High levels of industrially produced trans fat in popular fast foods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2009.149

The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients

31 March 2020

1 reference

PubMed

12 December 2020

Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus

1 reference

PubMed

12 December 2020

Vitamin D intake and vitamin D status of Australians

1 reference

PubMed

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2009.149

1 reference

21 August 2017

1 reference